Your browser doesn't support javascript.
loading
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
Yates, M; Watts, R A; Bajema, I M; Cid, M C; Crestani, B; Hauser, T; Hellmich, B; Holle, J U; Laudien, M; Little, M A; Luqmani, R A; Mahr, A; Merkel, P A; Mills, J; Mooney, J; Segelmark, M; Tesar, V; Westman, K; Vaglio, A; Yalçindag, N; Jayne, D R; Mukhtyar, C.
Affiliation
  • Yates M; Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK Norwich Medical School, University of East Anglia, Norwich, UK.
  • Watts RA; Norwich Medical School, University of East Anglia, Norwich, UK Department of Rheumatology, Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK.
  • Bajema IM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Cid MC; Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Crestani B; Assistance Publique-Hôpitaux de Paris, Department of Pulmonology, Bichat-Claude Bernard University Hospital, Paris, France.
  • Hauser T; Immunologie-Zentrum Zürich, Zürich, Switzerland.
  • Hellmich B; Vaskulits-Zentrum Süd, Klinik für Innere Medizin, Rheumatologie und Immunologie, Kreiskliniken Esslingen, Kirchheim-Teck, Germany.
  • Holle JU; Rheumazentrum Schleswig-Holstein Mitte, Neumünster, Germany.
  • Laudien M; Department of Otorhinolaryngology, Head and Neck Surgery, University of Kiel, Kiel, Germany.
  • Little MA; Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
  • Luqmani RA; Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom.
  • Mahr A; Department of Internal Medicine, Hôpital Saint-Louis, Université Paris 7 René Diderot, Paris, France.
  • Merkel PA; Division of Rheumatology and the Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Mills J; Vasculitis UK, West Bank House, Winster, Matlock, UK.
  • Mooney J; Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Segelmark M; Department of Medical and Health Sciences, Linköping University, Linköping, Sweden Department of Nephrology, Linköping University, Linköping, Sweden.
  • Tesar V; Department of Nephrology, 1st School of Medicine, Charles University, Prague, Czech Republic.
  • Westman K; Department of Nephrology, Lund University, Skåne University Hospital, Lund and Malmö, Sweden.
  • Vaglio A; Nephrology Unit, University Hospital of Parma, Parma, Italy.
  • Yalçindag N; Department of Ophthalmology, School of Medicine, Ankara University, Ankara, Turkey.
  • Jayne DR; Lupus and Vasculitis Unit, Addenbrooke's Hospital, Cambridge, UK.
  • Mukhtyar C; Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK.
Ann Rheum Dis ; 75(9): 1583-94, 2016 Sep.
Article in En | MEDLINE | ID: mdl-27338776
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Management / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2016 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease Management / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2016 Type: Article Affiliation country: United kingdom